Table 1 Profile of participant characteristics (n = 76)
From: Can colorectal cancer survivors recall their medications and doctor visits reliably?
Socio-demographics | n | % | Disease profile | n | % |
|---|---|---|---|---|---|
Sex | Tumour site | ||||
Male | 38 | 50% | Rectum | 17 | 22% |
Female | 38 | 50% | Colon | 59 | 78% |
Age (mean 65 years, SD 9.8 years) | Dukes Stage | ||||
31-40 | 2 | 3% | A | 17 | 22% |
41-50 | 4 | 5% | B | 22 | 29% |
51-60 | 14 | 18% | C | 18 | 24% |
61-70 | 32 | 42% | Unknown | 19 | 25% |
71-80 | 24 | 32% | Type of surgery | ||
Country of birth | No surgery | 4 | 1% | ||
Australia | 59 | 78% | Open surgery | 41 | 54% |
UK | 7 | 9% | Laparoscopic | 33 | 43% |
New Zealand | 5 | 7% | Polypectomy only | 1 | 1% |
Other | 5 | 7% | Chemotherapy | ||
Living arrangements | Yes | 45 | 59% | ||
Single live alone | 15 | 20% | No | 31 | 41% |
Single live with friends/family | 5 | 7% | Radiotherapy | ||
Single parent | 2 | 3% | Yes | 64 | 84% |
Couple not living with children | 38 | 50% | No | 12 | 16% |
Couple Living with Children | 14 | 18% | Stoma | ||
Other | 2 | 3% | No | 62 | 82% |
Private health insurance | Temporary | 9 | 12% | ||
No | 16 | 21% | Permanent | 5 | 7% |
Yes | 60 | 79% | Comorbid conditions | ||
Highest education | Diabetes | 9 | 12% | ||
Primary School | 5 | 7% | High cholesterol | 26 | 34% |
Secondary School | 35 | 46% | Hypertension | 29 | 38% |
Higher Education | 36 | 47% | Angina | 1 | 1.3% |
Employment situation | Peripheral vascular disease | 6 | 8% | ||
In paid work | 18 | 24% | Lung disease | 11 | 14% |
Work without pay | 4 | 5% | Depression, anxiety, nervous | 11 | 14% |
Unemployed | 2 | 3% | Gastrointestinal ulcer | 4 | 5% |
Retired | 37 | 49% | Arthritis | 26 | 34% |
Permanently unable to work | 2 | 3% | Osteoporosis | 8 | 11% |
Other | 11 | 14% | Kidney disease | 3 | 4% |
Missing | 2 | 3% | Any other cancer | 21 | 28% |
Total household income | |||||
<$25,000 | 19 | 25% | |||
$25,001 - $40,000 | 21 | 28% | |||
$40,001 - $65,000 | 10 | 13% | |||
$65,001 - $100,000 | 9 | 12% | |||
>$100,000 | 6 | 8% | |||
not stated | 11 | 14% |